Brooks Laboratories Limited (NSE:BROOKS)

Brooks Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	0.43	1.26	0.23	26.05	8.84
Cash & Short-Term Investments	12.48	0.43	1.26	0.23	26.05	8.84
Cash Growth	79.98%	-65.42%	440.95%	-99.11%	194.72%	123.21%
Accounts Receivable	-	199.92	163.16	127.54	176.62	136.98
Other Receivables	-	11.4	17.65	3.03	13.69	4.37
Receivables	-	211.33	180.84	130.57	190.31	141.35
Inventory	-	92.05	96.11	113.03	275.22	236.03
Prepaid Expenses	-	0.83	0.93	0.94	1.77	1.87
Other Current Assets	-	34.12	31.36	31.29	118.47	110.74
Total Current Assets	-	338.77	310.48	276.06	611.82	498.83
Property, Plant & Equipment	-	139.72	136	148.09	1,245	1,077
Long-Term Investments	-	735.54	429.13	640.26	2.78	3.28
Other Intangible Assets	-	0.09	0.73	1.99	6.31	6.88
Long-Term Deferred Tax Assets	-	-	-	-	13.55	-
Other Long-Term Assets	-	22.82	28.11	29.57	79.75	34.77
Total Assets	-	1,237	904.46	1,096	1,959	1,621
Accounts Payable	-	136.24	154.43	233.7	280	309.53
Accrued Expenses	-	21.96	16.54	23.18	32.34	42.04
Short-Term Debt	-	59	50.42	56.64	110.47	236.37
Current Portion of Long-Term Debt	-	0.33	-	-	38.76	33.07
Current Portion of Leases	-	2.8	2.43	2.47	1.97	-
Other Current Liabilities	-	8.11	6.65	14.23	25.25	15.13
Total Current Liabilities	-	228.44	230.48	330.21	488.79	636.14
Long-Term Debt	-	1.31	-	-	92.91	144.4
Long-Term Leases	-	12.4	3.57	6.02	8.49	-
Long-Term Deferred Tax Liabilities	-	-	-	-	-	32.3
Other Long-Term Liabilities	-	7.39	7.76	11.17	12.78	6.29
Total Liabilities	-	255.9	248.6	356.44	615.92	829.29
Common Stock	-	294.57	262.47	247.03	247.03	247.03
Additional Paid-In Capital	-	1,170	777.24	680	860.21	680
Retained Earnings	-	-486.52	-386.85	-190.93	-236.18	-138.49
Comprehensive Income & Other	-	2.81	3	3.43	3.84	2.94
Total Common Equity	981.04	981.04	655.85	739.53	874.9	791.48
Minority Interest	-	-	-	-	468.29	-
Shareholders' Equity	981.04	981.04	655.85	739.53	1,343	791.48
Total Liabilities & Equity	-	1,237	904.46	1,096	1,959	1,621
Total Debt	75.83	75.83	56.42	65.12	252.59	413.85
Net Cash (Debt)	-63.35	-75.39	-55.16	-64.89	-226.54	-405.01
Net Cash Per Share	-2.28	-2.81	-2.15	-2.63	-9.17	-16.40
Filing Date Shares Outstanding	29.49	29.46	26.25	24.7	24.7	24.7
Total Common Shares Outstanding	29.49	29.46	26.25	24.7	24.7	24.7
Working Capital	-	110.33	80.01	-54.15	123.04	-137.31
Book Value Per Share	36.33	33.30	24.99	29.94	35.42	32.04
Tangible Book Value	980.95	980.95	655.12	737.55	868.59	784.6
Tangible Book Value Per Share	36.33	33.30	24.96	29.86	35.16	31.76
Land	-	15.13	15.13	15.13	187.13	187.13
Buildings	-	38.89	38.89	38.45	447.98	442.72
Machinery	-	166.2	160.19	156.49	771.88	697.3
Construction In Progress	-	-	-	-	151.07	6.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.